Migraine Trials in Kagoshima, Japan
Conditions / Migraine / Kagoshima, Japan
Research into Migraine spans multiple therapeutic approaches and trial phases.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02629861 | Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine | COMPLETED | PHASE3 |
| NCT06323928 | A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments | ACTIVE_NOT_RECRUITING | — |
| NCT04396574 | A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine | TERMINATED | PHASE3 |
| NCT03559257 | A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine | COMPLETED | PHASE3 |
| NCT05156398 | Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects | RECRUITING | — |
| NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | RECRUITING | PHASE3 |
| NCT04396236 | A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine | TERMINATED | PHASE3 |
| NCT02638103 | Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine | COMPLETED | PHASE3 |
| NCT02621931 | Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine | COMPLETED | PHASE3 |
| NCT06323928 | A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments | ACTIVE_NOT_RECRUITING | — |